Nathalie Compagnone
Chief Executive Officer at Innovative Concepts in Drug Development SAS
Profile
Nathalie Compagnone is the founder and currently holds the position of Chief Executive & Scientific Officer at Innovative Concepts in Drug Development SAS, which she founded in 2007.
She previously worked as Head-Laboratory at The University of California, San Francisco and as Principal at Trophos SA. Dr. Compagnone holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Université de Franche-Comté.
Nathalie Compagnone active positions
| Companies | Position | Start |
|---|---|---|
Innovative Concepts in Drug Development SAS
 Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Chief Executive Officer | 31/12/2006 |
Former positions of Nathalie Compagnone
| Companies | Position | End |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Training of Nathalie Compagnone
| Rutgers State University of New Jersey | Masters Business Admin |
| Université de Franche-Comté | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |
- Stock Market
- Insiders
- Nathalie Compagnone
